A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
Clinical trial NCT03673501 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03673501
- Sponsor
- Deciphera Pharmaceuticals, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-08
- Primary completion
- 2021-09-01
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.